(Q37253003)

19 August 2017

1 reference

title

Local treatment of vulvovaginal candidosis : general and practical considerations (English)

1 reference

19 August 2017

1 reference

José das Neves

1

1 reference

19 August 2017

Eugénia Pinto

2

1 reference

19 August 2017

Branca Teixeira

3

1 reference

19 August 2017

Gustavo Dias

4

1 reference

19 August 2017

Patrocínia Rocha

5

1 reference

19 August 2017

Teresa Cunha

6

1 reference

19 August 2017

Bárbara Santos

7

1 reference

19 August 2017

Maria H Amaral

8

1 reference

19 August 2017

Maria F Bahia

9

1 reference

19 August 2017

publication date

1 January 2008

1 reference

19 August 2017

1 reference

19 August 2017

volume

68

1 reference

19 August 2017

issue

13

1 reference

19 August 2017

page(s)

1787-1802

1 reference

Treatment of Torulopsis glabrata vaginitis: retrospective review of boric acid therapy

19 August 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F00003495-200868130-00002

An evaluation of butoconazole nitrate 2% site release vaginal cream (Gynazole-1) compared to fluconazole 150 mg tablets (Diflucan) in the time to relief of symptoms in patients with vulvovaginal candidiasis

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F00003495-200868130-00002

Safety and efficacy of bedtime versus daytime administration of the miconazole nitrate 1200 mg vaginal ovule insert to treat vulvovaginal candidiasis

21 January 2018

1 reference

12 December 2020

Association between atopy and recurrent vaginal candidiasis

1 reference

12 December 2020

Current and emerging azole antifungal agents

1 reference

12 December 2020

Butoconazole nitrate 2% for vulvovaginal candidiasis. New, single-dose vaginal cream formulation vs. seven-day treatment with miconazole nitrate. Gynazole 1 Study Group

1 reference

12 December 2020

Antimicrobial activity of essential oils and other plant extracts.

1 reference

12 December 2020

Prevalence of Candida glabrata and its response to boric acid vaginal suppositories in comparison with oral fluconazole in patients with diabetes and vulvovaginal candidiasis.

1 reference

12 December 2020

Gels as vaginal drug delivery systems.

1 reference

12 December 2020

Polysorbate 80 hypersensitivity

1 reference

12 December 2020

Zeamatin, clotrimazole and nikkomycin Z in therapy of a Candida vaginitis model

1 reference

12 December 2020

Treatment of vaginitis caused by Candida glabrata: use of topical boric acid and flucytosine

1 reference

12 December 2020

Anticandidal immunity and vaginitis: novel opportunities for immune intervention.

1 reference

12 December 2020

Epidemiology and outcomes associated with moderate to heavy Candida colonization during pregnancy. Vaginal Infections and Prematurity Study Group

1 reference

12 December 2020

Vulvovaginal candidosis

1 reference

12 December 2020

Risk factors for recurrent vulvovaginal candidiasis in women receiving maintenance antifungal therapy: results of a prospective cohort study

1 reference

12 December 2020

Effect of antibiotic use on the prevalence of symptomatic vulvovaginal candidiasis

1 reference

12 December 2020

Prolonged antifungal effects of clotrimazole-containing mucoadhesive thermosensitive gels on vaginitis

1 reference

12 December 2020

Treatment of recurrent vulvovaginal candidiasis.

1 reference

12 December 2020

Hormonal contraception and risk of sexually transmitted disease acquisition: results from a prospective study

1 reference

12 December 2020

Preparation, in vitro and in vivo evaluation of liposomal/niosomal gel delivery systems for clotrimazole

1 reference

12 December 2020

Vulvovaginal candidiasis: epidemiologic, diagnostic, and therapeutic considerations.

1 reference

12 December 2020

The infrequent use of office-based diagnostic tests for vaginitis

1 reference

12 December 2020

Severe vulvovaginitis associated with intravaginal nystatin therapy

1 reference

12 December 2020

Stress as a cause of chronic recurrent vulvovaginal candidosis and the effectiveness of the conventional antimycotic therapy

1 reference

12 December 2020

Guideline vulvovaginal candidosis: Guideline of the German Dermatological Society, the German Speaking Mycological Society and the Working Group for Infections and Infectimmunology of the German Society for Gynecology and Obstetrics

1 reference

12 December 2020

Evidence-based guidelines for non-prescription treatment of vulvovaginal candidiasis (VVC)

1 reference

12 December 2020

Effect of lactobacillus in preventing post-antibiotic vulvovaginal candidiasis: a randomised controlled trial

1 reference

12 December 2020

Teratogenic effects of vaginal boric acid treatment during pregnancy

1 reference

12 December 2020

Immunotherapeutic approaches to enhance protective immunity against Candida vaginitis

1 reference

12 December 2020

The secreted aspartyl proteinases Sap1 and Sap2 cause tissue damage in an in vitro model of vaginal candidiasis based on reconstituted human vaginal epithelium

1 reference

12 December 2020

Risk assessment, symptoms, and signs as predictors of vulvovaginal and cervical infections in an urban US STD clinic: implications for use of STD algorithms.

1 reference

12 December 2020

Torulopsis glabrata vaginitis

1 reference

12 December 2020

The in vitro activity of vaginal Lactobacillus with probiotic properties against Candida

1 reference

12 December 2020

Double-blind randomized dose-finding study in acute vulvovaginal candidosis. Comparison of flutrimazole site-releaseR cream (1, 2 and 4%) with placebo site-releaseR vaginal cream

1 reference

12 December 2020

Sexually transmitted diseases treatment guidelines, 2006.

1 reference

12 December 2020

Probiotics for prevention of recurrent vulvovaginal candidiasis: a review.

1 reference

12 December 2020

Topical flucytosine therapy for chronic recurrent Candida tropicalis infections

1 reference

12 December 2020

[Effectiveness and safety of ciclopirox olamine 1% vaginal cream versus terconazole 0.8% vaginal cream in the treatment of genital candidiasis]

1 reference

12 December 2020

Treatment of vaginal candidiasis: orally or vaginally?

1 reference

12 December 2020

Vaginal yeasts in the era of "over the counter" antifungals

1 reference

12 December 2020

Immunopathogenesis of recurrent vulvovaginal candidiasis.

1 reference

12 December 2020

Self-medication with vaginal antifungal drugs: physicians' experiences and women's utilization patterns

1 reference

12 December 2020

Usage of antifungal drugs for therapy of genital Candida infections, purchased as over-the-counter products or by prescription: I. Analyses of a unique database

1 reference

12 December 2020

Vaginal drug administration in the hospital setting

1 reference

12 December 2020

Potentiation of acenocoumarol during vaginal administration of miconazole

1 reference

12 December 2020

Attitudes, perceptions and knowledge about the vagina: the International Vagina Dialogue Survey.

1 reference

12 December 2020

Combined topical flucytosine and amphotericin B for refractory vaginal Candida glabrata infections

1 reference

12 December 2020

Trends in prescribing for vulvovaginal candidiasis in the United States.

1 reference

12 December 2020

Efficacy and tolerability of a new chlorhexidine-based vaginal gel in vaginal infections

1 reference

12 December 2020

Vaginal infections in human immunodeficiency virus-infected women

1 reference

12 December 2020

Vaginitis due to Candida krusei: epidemiology, clinical aspects, and therapy

1 reference

12 December 2020

Vaginal candidosis: epidemiological and etiological factors

1 reference

12 December 2020

Chronic vaginal candidiasis. Management in the postmenopausal patient

1 reference

12 December 2020

Vaginal microbiology of women with acute recurrent vulvovaginal candidiasis

1 reference

12 December 2020

Advancing vaginal drug delivery

1 reference

12 December 2020

Vaginal discharge--causes, diagnosis, and treatment

1 reference

12 December 2020

Vulvovaginal candidiasis: clinical manifestations, risk factors, management algorithm

1 reference

12 December 2020

Introduction to antifungal drugs

1 reference

12 December 2020

Management of common vulval conditions

1 reference

12 December 2020

Effects of reproductive hormones on experimental vaginal candidiasis

1 reference

12 December 2020

Guidelines for treatment of candidiasis

1 reference

12 December 2020

Use of antifungal drugs in pregnancy: a focus on safety

1 reference

12 December 2020

A study of 72 patients with contact allergy to tioconazole

1 reference

12 December 2020

Allergic contact dermatitis from benzyl alcohol in multiple medicaments

1 reference

12 December 2020

Chronic vulvovaginal candidiasis.

1 reference

12 December 2020

Vaginal heat shock protein expression in symptom-free women with a history of recurrent vulvovaginitis

1 reference

12 December 2020

Characterisation and in vitro evaluation of bioadhesive liposome gels for local therapy of vaginitis

1 reference

12 December 2020

Antifungal drugs in pregnancy: a review

1 reference

12 December 2020

1 reference

12 December 2020

Antifungal activity of the components of Melaleuca alternifolia (tea tree) oil.

1 reference

12 December 2020

Single-dose miconazole nitrate vaginal ovule in the treatment of vulvovaginal candidiasis: two single-blind, controlled studies versus miconazole nitrate 100 mg cream for 7 days

1 reference

12 December 2020

Oral versus intra-vaginal imidazole and triazole anti-fungal agents for the treatment of uncomplicated vulvovaginal candidiasis (thrush): a systematic review

1 reference

12 December 2020

Immunity in vaginal candidiasis

1 reference

12 December 2020

Treatment of non-albicans Candida vaginitis with amphotericin B vaginal suppositories

1 reference

12 December 2020

Management of patients with recurrent vulvovaginal candidiasis

1 reference

12 December 2020

Comparison of the moisturization efficacy of two vaginal moisturizers: Pectin versus polycarbophil technologies.

1 reference

12 December 2020

Local treatment of vaginal infections of varying etiology with dequalinium chloride or povidone iodine. A randomised, double-blind, active-controlled, multicentric clinical study

1 reference

12 December 2020

Fungal species changes in the female genital tract

1 reference

12 December 2020

Adhesion in Candida spp.

1 reference

12 December 2020

Mucoadhesive, thermosensitive, prolonged-release vaginal gel for clotrimazole:beta-cyclodextrin complex

1 reference

12 December 2020

New immunotherapeutic strategies to control vaginal candidiasis.

1 reference

12 December 2020

Preparation and evaluation of proliposomes containing clotrimazole

1 reference

12 December 2020

History and update on host defense against vaginal candidiasis

1 reference

12 December 2020

Oral versus intra-vaginal imidazole and triazole anti-fungal treatment of uncomplicated vulvovaginal candidiasis (thrush)

1 reference

12 December 2020

The association of Candida infection with intrauterine contraceptive device.

1 reference

12 December 2020

Potentiation of warfarin's hypoprothrombinemic effect with miconazole vaginal suppositories

1 reference

12 December 2020

Topical treatment of vaginal candidosis with sertaconazole and econazole sustained-release suppositories

1 reference

12 December 2020

Prevalence and risk factors for vaginal Candida colonization in women with type 1 and type 2 diabetes

1 reference

12 December 2020

Over-the-counter antifungal drug misuse associated with patient-diagnosed vulvovaginal candidiasis

1 reference

12 December 2020

Facts and myths on recurrent vulvovaginal candidosis--a review on epidemiology, clinical manifestations, diagnosis, pathogenesis and therapy.

1 reference

12 December 2020

Topical antiseptics as an alternative in the treatment of acute vulvovaginal candidosis

1 reference

12 December 2020

Antifungal activity of Thymus oils and their major compounds.

1 reference

12 December 2020

Low prevalence of genital candidiasis in children

1 reference

12 December 2020

Resistance of Candida species to antifungal agents: molecular mechanisms and clinical consequences

1 reference

12 December 2020

10.2165/00003495-200868130-00002

Identifiers

DOI

1 reference

Dimensions Publication ID

19 August 2017

1044585979

0 references

1 reference